Edge Therapeutics, Inc. Business Operations Contracts & Agreements
7 Contracts & Agreements
- Collaboration Agreements (3 contracts)
- Development Agreements (2)
- Indemnification Agreements (1)
- Supply Agreements (1)
- First Amendment to Preclinical/Clinical Collaboration and License Agreement dated as of November 22, 2021 by and between PDS Biotechnology Corporation and Farmacore Biotechnology (Filed With SEC on August 8, 2022)
- Amended and Restated Preclinical/Clinical Collaboration and License Agreement dated as of November 30, 2020 by and between PDS Biotechnology Corporation and Farmacore Biotechnology (Filed With SEC on August 8, 2022)
- Amendment No. 1 to Clinical Trial Collaboration and Supply Agreement, dated as of October 28, 2019, by and between PDS Biotechnology Corporation and MSD International GmbH (Filed With SEC on November 7, 2019)
- Manufacturing and Supply Agreement by and between the Company and Oakwood Laboratories LLC, dated as of June 30, 2017 (Filed With SEC on August 1, 2017)
- Amended and Restated Master Formulation Development Agreement by and between the Company and Oakwood Laboratories LLC, dated as of June 30, 2017 (Filed With SEC on August 1, 2017)
- Master Formulation Development Agreement by and between the Company and Oakwood Laboratories LLC, dated as of March 12, 2015 (Filed With SEC on March 8, 2016)
- INDEMNIFICATION AGREEMENT (Filed With SEC on August 14, 2015)
